Detalhe da pesquisa
1.
Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med
; 388(2): 117-127, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331190
2.
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
Lancet
; 403(10424): 379-390, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38109916
3.
Uremia Impedes Skeletal Myocyte Myomixer Expression and Fusogenic Activity: Implication for Uremic Sarcopenia.
Am J Pathol
; 194(5): 759-771, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38637109
4.
Coordinated demethylation of H3K9 and H3K27 is required for rapid inflammatory responses of endothelial cells.
EMBO J
; 39(7): e103949, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32125007
5.
How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial.
Nephrol Dial Transplant
; 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38323492
6.
Comparison of estimated glomerular filtration rate change with sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists among people with diabetes: A propensity-score matching study.
Diabetes Obes Metab
; 26(6): 2422-2430, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38528820
7.
Factors affecting the sodium-glucose cotransporter 2 inhibitors-related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database.
Diabetes Obes Metab
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38719436
8.
Neutrophil Protein Kinase R Mediates Endothelial Adhesion and Migration by the Promotion of Neutrophil Actin Polymerization.
J Immunol
; 208(9): 2173-2183, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35396220
9.
Cardiovascular Outcomes of KCNJ5 mutated Aldosterone-Producing Adenoma: A Systematic Review.
Endocr Pract
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657793
10.
eGFR slope as a surrogate endpoint for end-stage kidney disease in patients with diabetes and eGFR > 30 mL/min/1.73 m2 in the J-DREAMS cohort.
Clin Exp Nephrol
; 28(2): 144-152, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806976
11.
Factors affecting responsiveness of vadadustat in patients with anemia associated with chronic kidney disease: a post-hoc subgroup analysis of Japanese phase 3 randomized studies.
Clin Exp Nephrol
; 28(5): 391-403, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530490
12.
Effects of NRF2 polymorphisms on safety and efficacy of bardoxolone methyl: subanalysis of TSUBAKI study.
Clin Exp Nephrol
; 28(3): 225-234, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37962746
13.
Association of serum magnesium levels with renal prognosis in patients with chronic kidney disease.
Clin Exp Nephrol
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506982
14.
Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEY.
Clin Exp Nephrol
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643286
15.
Kidney outcomes associated with haematuria and proteinuria trajectories among patients with IgA nephropathy in real-world clinical practice: The Japan Chronic Kidney Disease Database.
Nephrology (Carlton)
; 29(2): 65-75, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871587
16.
Global variations in funding and use of hemodialysis accesses: an international report using the ISN Global Kidney Health Atlas.
BMC Nephrol
; 25(1): 159, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720263
17.
Oxidized alkyl phospholipids stimulate sodium transport in proximal tubules via a nongenomic PPARγ-dependent pathway.
J Biol Chem
; 298(3): 101681, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124009
18.
Antibody recognition of complement factor H reveals a flexible loop involved in atypical hemolytic uremic syndrome pathogenesis.
J Biol Chem
; 298(6): 101962, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452676
19.
Use of antibiotics as a therapeutic approach to prevent AKI-to-CKD progression.
Kidney Int
; 104(3): 418-420, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37599013
20.
Another piece in the puzzle of kidney fibrosis.
Kidney Int
; 103(6): 1020-1023, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210192